MRKR logo

Marker Therapeutics, Inc.

MRKR
Healthcare|Biotechnology|US
$0.89
-0.00 (-0.30%)
DCF Value
$1.08
Tangible Book / Share
$0.63
Cash / Share
$0.59
Next Earnings Report
Mar 24, 2027
EPS est. -$0.22 · Revenue est. $715.3K
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.

Upcoming Data Readouts (2)

Feb 2028
Est. completion
P1Non-Hodgkin Lymphoma, Adult
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
NCT05798897n=79
Sep 2029
Est. completion
P1Acute Myeloid Leukemia, in Relapse
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
NCT06552416n=40

Awaiting Results (1)

Trials past primary completion date but still active — data readout may be imminent.

Nov 2026
NA
Weight Loss and Endocrine Disrupting Chemicals (EDCs): Lifestyle Interventions to Lose Weight and Reduce EDC Exposure in Individuals With Overweight/Obesity
NCT07560579

Recent Press Releases

Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant to Advance MT-601 in Pancreatic Cancer
Oct 19, 2026 · GlobeNewsWire
Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies
Sep 22, 2026 · GlobeNewsWire

SEC Filings (56)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 19, 20268-KMaterial eventDocumentIndex
Aug 14, 202610-QQuarterly reportDocumentIndex
May 15, 202610-QQuarterly reportDocumentIndex
May 4, 20268-KMaterial eventDocumentIndex
Mar 20, 2026DEFA14AProxy / shareholder voteDocumentIndex
Mar 20, 2026ARSAnnual report to holdersDocumentIndex
Mar 20, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 19, 20268-KMaterial eventDocumentIndex
Mar 18, 202610-KAnnual reportDocumentIndex
Mar 10, 2026PRE 14AProxy / shareholder voteDocumentIndex
Feb 9, 20268-KMaterial eventDocumentIndex
Nov 17, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Nov 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 14, 20258-KMaterial eventDocumentIndex
Nov 13, 202510-QQuarterly reportDocumentIndex
Nov 5, 20258-KMaterial eventDocumentIndex
Oct 6, 20258-KMaterial eventDocumentIndex
Aug 26, 20258-KMaterial eventDocumentIndex
Aug 20, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Aug 19, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Aug 18, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Aug 14, 202510-QQuarterly reportDocumentIndex
Aug 12, 20258-KMaterial eventDocumentIndex
Aug 5, 2025424B7Offering prospectusDocumentIndex
Jun 17, 20258-KMaterial eventDocumentIndex
Jun 9, 20258-KMaterial eventDocumentIndex
May 20, 20258-KMaterial eventDocumentIndex
May 15, 202510-QQuarterly reportDocumentIndex
May 15, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Apr 24, 2025ARSAnnual report to holdersDocumentIndex
Apr 24, 2025DEFA14AProxy / shareholder voteDocumentIndex
Apr 24, 2025DEF 14AProxy / shareholder voteDocumentIndex
Mar 31, 20258-KMaterial eventDocumentIndex
Mar 31, 202510-KAnnual reportDocumentIndex
Mar 27, 20258-KMaterial eventDocumentIndex
Mar 4, 20258-K/AMaterial eventDocumentIndex
Feb 19, 20258-KMaterial eventDocumentIndex
Feb 14, 2025SC 13GPassive 5%+ stakeDocumentIndex
Feb 14, 2025SC 13GPassive 5%+ stakeDocumentIndex
Feb 4, 2025DEFA14AProxy / shareholder voteDocumentIndex